KR20210034615A - 외용 제제 - Google Patents

외용 제제 Download PDF

Info

Publication number
KR20210034615A
KR20210034615A KR1020217004351A KR20217004351A KR20210034615A KR 20210034615 A KR20210034615 A KR 20210034615A KR 1020217004351 A KR1020217004351 A KR 1020217004351A KR 20217004351 A KR20217004351 A KR 20217004351A KR 20210034615 A KR20210034615 A KR 20210034615A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
pain
external use
compound
mass
Prior art date
Application number
KR1020217004351A
Other languages
English (en)
Korean (ko)
Inventor
마사야스 다나카
요시히로 오야마다
요시노리 다카다
Original Assignee
다이니뽄 스미토모 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다이니뽄 스미토모 세이야쿠 가부시키가이샤 filed Critical 다이니뽄 스미토모 세이야쿠 가부시키가이샤
Publication of KR20210034615A publication Critical patent/KR20210034615A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020217004351A 2018-07-19 2019-07-18 외용 제제 KR20210034615A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2018-136147 2018-07-19
JP2018136147 2018-07-19
PCT/JP2019/028251 WO2020017585A1 (fr) 2018-07-19 2019-07-18 Préparation médicinale à usage externe

Publications (1)

Publication Number Publication Date
KR20210034615A true KR20210034615A (ko) 2021-03-30

Family

ID=69165160

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217004351A KR20210034615A (ko) 2018-07-19 2019-07-18 외용 제제

Country Status (12)

Country Link
US (1) US11925621B2 (fr)
EP (1) EP3824887A4 (fr)
JP (1) JP7391848B2 (fr)
KR (1) KR20210034615A (fr)
CN (1) CN112423749A (fr)
AU (1) AU2019306705A1 (fr)
BR (1) BR112021000183A8 (fr)
CA (1) CA3105465A1 (fr)
EA (1) EA202190317A1 (fr)
IL (1) IL280118A (fr)
MX (1) MX2021000714A (fr)
WO (1) WO2020017585A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI436986B (zh) * 2008-12-26 2014-05-11 Dainippon Sumitomo Pharma Co 新穎之２環性雜環化合物
AU2021410896A1 (en) 2020-12-23 2023-06-29 Alphanavi Pharma Inc. Oral solid preparation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010074193A1 (fr) 2008-12-26 2010-07-01 大日本住友製薬株式会社 Nouveau composé hétérocyclique à cycle double

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001296799A1 (en) 2000-10-06 2002-04-15 Neurogen Corporation Benzimidazole and indole derivatives as crf receptor modulators
ATE359274T1 (de) 2000-11-21 2007-05-15 Vertex Pharma Imidazol- und benzimidazol- caspase inhibitoren und deren verwendung
JP5667934B2 (ja) 2010-06-28 2015-02-12 大日本住友製薬株式会社 新規２環性複素環化合物からなる医薬

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010074193A1 (fr) 2008-12-26 2010-07-01 大日本住友製薬株式会社 Nouveau composé hétérocyclique à cycle double

Also Published As

Publication number Publication date
JPWO2020017585A1 (ja) 2021-08-02
EA202190317A1 (ru) 2021-04-20
BR112021000183A2 (pt) 2021-06-01
MX2021000714A (es) 2021-03-25
EP3824887A4 (fr) 2022-04-13
BR112021000183A8 (pt) 2022-12-06
EP3824887A1 (fr) 2021-05-26
AU2019306705A1 (en) 2021-01-28
WO2020017585A1 (fr) 2020-01-23
CN112423749A (zh) 2021-02-26
US11925621B2 (en) 2024-03-12
JP7391848B2 (ja) 2023-12-05
CA3105465A1 (fr) 2020-01-23
IL280118A (en) 2021-03-01
US20210322385A1 (en) 2021-10-21

Similar Documents

Publication Publication Date Title
US20210177782A1 (en) High concentration local anesthetic formulations
US9415108B2 (en) Compositions for transdermal delivery of active agents
CA2696632C (fr) Formulations anesthesiques locales a concentration elevee
TWI296531B (en) Transdermal adhesive preparations for topical administration of fentanyl
KR20210034615A (ko) 외용 제제
WO2005072775A1 (fr) Analgesique anti-inflammatoire á usage externe
WO2008088756A1 (fr) Compositions dermiques d'amides substituées et utilisation de celles-ci comme médication contre la douleur et le prurit
TWI729371B (zh) 治療搔癢症的組合物與方法
ZA200506286B (en) Therapeutic agent for hemorrhoidal disease
US20050158371A1 (en) Novel external agent
JP2024507266A (ja) ヒドロゲル組成物、ならびに放射線によって引き起こされる皮膚損傷の予防および／または処置におけるその使用
BR122023027784A2 (pt) Preparação medicinal para uso externo
EA045467B1 (ru) Лекарственный препарат для наружного применения
CA2727154C (fr) Preparation analgesique/antiprurigineuse contenant de l'oxybuprocaine pour application externe
CA2499620C (fr) Preparation externe contenant de l'acide acetylsalicylique pour inhiber la formation de cicatrices cheloidiennes